-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Eton Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2019 to Q2 2024.
- Eton Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$52K, a 108% decline year-over-year.
- Eton Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$110K, a 144% decline year-over-year.
- Eton Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $503K.
- Eton Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$761K, a 24.4% increase from 2021.
- Eton Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.01M, a 17.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)